
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
ZMAT3 (zinc finger matrin-type 3) encodes a nuclear zinc finger-containing protein involved in transcriptional regulation. Its expression is induced by wild-type p53, and increased ZMAT3 expression can inhibit tumor cell growth, supporting a role in p53-dependent growth regulation. Through its nuclear localization and zinc finger domains, ZMAT3 may contribute to cellular responses that regulate proliferation and maintenance of appropriate cell growth.
The U-2 OS cell line is a foundational human osteosarcoma model established in 1964 by J. Ponten and E. Saksela from a moderately differentiated osteogenic sarcoma of the tibia of a 15-year-old girl. Originally designated as 2T and referenced in image_2f37aa.png, this adherent epithelial-like model is documented to secrete osteosarcoma-derived growth factor (ODGF) and express functional insulin-like growth factor (IGF-1) receptors, insulin-like growth factor-II/Mannose-6-phosphate (IGF-II/M6P) receptors, and IGF-II. Serving as a gold-standard in vitro platform, it is extensively utilized in biomedical research for studying bone oncology pathways, cellular response kinetics, and advanced transfection signaling mechanisms.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 2
Reference Transcript: NM_001375827
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?